Diligence memo · auto-generated · as of July 2, 2026
Iota Biosciences, Inc.
Iota Biosciences, Inc. has raised $15M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
Iota Biosciences, Inc. operates in Biotech / Pharma, based in BERKELEY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Iota Biosciences, Inc. has raised $15M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $15M on 2018-05-04.
Most recent recorded round closed around 2018-05-04.
Valuation (modeled)modeled
Provath models Iota Biosciences, Inc. at approximately $552M (range $31M–$2.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 8.2 yr ago; this sector typically re-raises about every 15 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 69% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 91% of those peers.
Closest niche peers: Akoya Biosciences, Inc., Bird Rock Bio, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.